Europe Oncology Market Databank
The Oncology market was valued at $275,700.0 Million in 2020, and is projected to reach $400,345.5 Million by 2029 growing at a CAGR of 4.28% from 2021 to 2029. Cancer treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated to reach $201,161.7 Million by 2029 with the highest CAGR of 4.43%.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
- 1. GLOBAL ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
- 1.1. OVERVIEW
- 1.2. CANCER DIAGNOSTICS
- 1.2.1 CANCER DIAGNOSTICS MARKET, BY REGION
- 1.2.1.1 North America Cancer diagnostics Market, By Country
- 1.2.1.2 Europe Cancer diagnostics Market, By Country
- 1.2.1.3 Asia-Pacific Cancer diagnostics Market, By Country
- 1.2.1.4 Rest of World Cancer diagnostics Market, By Country
- 1.3. CANCER TREATMENT
- 1.3.1 CANCER TREATMENT MARKET, BY REGION
- 1.3.1.1 North America Cancer treatment Market, By Country
- 1.3.1.2 Europe Cancer treatment Market, By Country
- 1.3.1.3 Asia-Pacific Cancer treatment Market, By Country
- 1.3.1.4 Rest of World Cancer treatment Market, By Country
- 2. GLOBAL ONCOLOGY MARKET, BY CANCER TYPE
- 2.1. OVERVIEW
- 2.2. LUNG CANCER
- 2.2.1 LUNG CANCER MARKET, BY REGION
- 2.2.1.1 North America Lung cancer Market, By Country
- 2.2.1.2 Europe Lung cancer Market, By Country
- 2.2.1.3 Asia-Pacific Lung cancer Market, By Country
- 2.2.1.4 Rest of World Lung cancer Market, By Country
- 2.3. PROSTATE CANCER
- 2.3.1 PROSTATE CANCER MARKET, BY REGION
- 2.3.1.1 North America Prostate cancer Market, By Country
- 2.3.1.2 Europe Prostate cancer Market, By Country
- 2.3.1.3 Asia-Pacific Prostate cancer Market, By Country
- 2.3.1.4 Rest of World Prostate cancer Market, By Country
- 2.4. COLON & RECTAL CANCER
- 2.4.1 COLON & RECTAL CANCER MARKET, BY REGION
- 2.4.1.1 North America Colon & rectal cancer Market, By Country
- 2.4.1.2 Europe Colon & rectal cancer Market, By Country
- 2.4.1.3 Asia-Pacific Colon & rectal cancer Market, By Country
- 2.4.1.4 Rest of World Colon & rectal cancer Market, By Country
- 2.5. LIVER CANCER
- 2.5.1 LIVER CANCER MARKET, BY REGION
- 2.5.1.1 North America Liver cancer Market, By Country
- 2.5.1.2 Europe Liver cancer Market, By Country
- 2.5.1.3 Asia-Pacific Liver cancer Market, By Country
- 2.5.1.4 Rest of World Liver cancer Market, By Country
- 2.6. BREAST CANCER
- 2.6.1 BREAST CANCER MARKET, BY REGION
- 2.6.1.1 North America Breast cancer Market, By Country
- 2.6.1.2 Europe Breast cancer Market, By Country
- 2.6.1.3 Asia-Pacific Breast cancer Market, By Country
- 2.6.1.4 Rest of World Breast cancer Market, By Country
- 2.7. OTHER CANCER TYPES
- 2.7.1 OTHER CANCER TYPES MARKET, BY REGION
- 2.7.1.1 North America Other Cancer Types Market, By Country
- 2.7.1.2 Europe Other Cancer Types Market, By Country
- 2.7.1.3 Asia-Pacific Other Cancer Types Market, By Country
- 2.7.1.4 Rest of World Other Cancer Types Market, By Country
- 3. GLOBAL ONCOLOGY MARKET, BY REGION
- 3.1. OVERVIEW
- 3.2. EUROPE
- 3.2.1 EUROPE ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
- 3.2.2 EUROPE ONCOLOGY MARKET, BY CANCER TYPE
- 3.2.3 EUROPE ONCOLOGY MARKET, BY COUNTRY
- 3.2.3.1 Germany
- 3.2.3.1.1 Germany Oncology Market, By By Cancer Diagnostics & Treatment
- 3.2.3.1.2 Germany Oncology Market, By Cancer Type
- 3.2.3.2 France
- 3.2.3.2.1 France Oncology Market, By By Cancer Diagnostics & Treatment
- 3.2.3.2.2 France Oncology Market, By Cancer Type
- 3.2.3.3 UK
- 3.2.3.3.1 UK Oncology Market, By By Cancer Diagnostics & Treatment
- 3.2.3.3.2 UK Oncology Market, By Cancer Type
- 3.2.3.4 Italy
- 3.2.3.4.1 Italy Oncology Market, By By Cancer Diagnostics & Treatment
- 3.2.3.4.2 Italy Oncology Market, By Cancer Type
- 3.2.3.5 Spain
- 3.2.3.5.1 Spain Oncology Market, By By Cancer Diagnostics & Treatment
- 3.2.3.5.2 Spain Oncology Market, By Cancer Type
- 3.2.3.6 Rest of Europe
- 3.2.3.6.1 Rest of Europe Oncology Market, By By Cancer Diagnostics & Treatment
- 3.2.3.6.2 Rest of Europe Oncology Market, By Cancer Type
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook